Examens immunochimiques (avec équipement)

This tender for immuno-chemical examinations offers a clear description and structured documentation, but lacks specific evaluation criteria and details on green or social aspects, impacting fairness and sustainability scores.

The tender has a clear procedure, a valid CPV code (though generic), and no apparent disputes. Deadlines are reasonable. The absence of explicit mention of regulatory compliance for this specific type of procurement prevents a higher score.

The title and description are clear. Requirements are outlined in attached documents. However, the AI extraction indicates 'Information not provided in the document summaries' for several key requirement types, suggesting potential gaps in the publicly visible summary.

Basic information, deadlines, and duration are specified. Three documents are provided, including required forms and technical specifications. However, crucial details regarding exclusion grounds, eligibility, technical, and financial requirements are marked as 'Information not provided in the document summaries'.

While the tender is open and uses e-procurement, the reported 'Restricted document access' and 'No evaluation criteria specified' significantly undermine fairness. The estimated value of 1.00 EUR is highly unusual and could indicate a lack of transparency or a placeholder, impacting objective comparison.

E-procurement is indicated. However, 'No e-submission' is flagged in the checks, which is a contradiction. Document URLs are not explicitly provided in the summary. Financing information and contract start date are not detailed.

Key fields like title, reference, organization, deadlines, and duration are populated. There are no reported disputes or suspensions. Dates appear logical. The generic CPV code does not allow for deeper consistency checks.

The tender explicitly states 'Not green procurement', 'No social criteria', 'No innovation focus', and 'Not EU funded'. This significantly lowers the score as no sustainability aspects are considered.